ADVERTISEMENT

 

Share

    


Home / Attend / ACCC 42nd National Oncology Conference

ACCC 42nd National Oncology Conference

NOC-2025-Venue-2304x711

ACCC 42nd National Oncology Conference

October 15–17, 2025
Denver, Colorado

Join cancer program administrators, operations leaders, clinicians, and other members of the multidisciplinary care team to learn, connect and be inspired by the innovation happening now to elevate the quality of cancer care.
LEARN MORE AND REGISTER

ACCC-2025-Innovator-Awards-800x800In its 15th year, the ACCC Innovator Awards recognize visionary and compelling ideas in oncology from ACCC Cancer Program Members nationwide who will present their work at the 42nd National Oncology Conference.

View the 2025 Winners

In case you couldn’t join us in Minneapolis, check out highlights from the 2024 NOC:

ACCC hosted its 41st National Oncology Conference (NOC) in Minneapolis, Minnesota, in October 2024, marking 50 years of innovative service and collaboration. Centered around the theme Realizing Innovation, the conference brought together oncology professionals, clinicians, researchers, nurses, advanced practice providers, navigators, and patient advocates to explore practical strategies for enhancing community engagement and equity in cancer care, share treatment models from around the world, and showcase strategies for implementing AI and innovative technologies into cancer care.

One highlight of the conference was the 2024 ACCC Innovator Awards, which recognized institutions and professionals pioneering innovative solutions in oncology care.

Awardees included:

  • St Luke’s University Health Network, St Luke’s Cancer Center
  • The University of Colorado Cancer Center
  • RWJ Barnabas Health Rutgers Cancer Institute of New Jersey, Cooperman Barnabas Medical Center
  • Mercy Oncology Services
  • The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
  • Munson Healthcare, Cowell Family Cancer Center

This year’s conference also featured its first international panel, where cancer care providers from Australia, Brazil, Egypt, Mexico, Nigeria, Puerto Rico, and Sweden shared insights into overcoming cultural and systemic barriers in cancer care. One panelist, Modupe Elebute-Odunsi, MD, MBBS, MD, FRCP, FRCPath, founder and CEO of Marcelle Ruth Cancer Centre and Specialist Hospital in Nigeria, stressed the importance of culturally competent solutions to improve patient outcomes in diverse populations.

In addition to the international panel, the conference offered 2 session tracks focused on the 2024-2025 ACCC President’s Theme Reimagining Community Engagement and Equity in Cancer. Discussions centered on improving equitable access to cancer care, fostering patient engagement, and addressing disparities. Keynote speaker Kevin Fiori, MD, MPH, MSc, FAAP, underscored the need for integrating social drivers of health (SDOH) into medical care, as SDOH account for 40% of a person’s quality of health. His address highlighted the critical role that community health workers can play in breaking down barriers to care and improving patient outcomes. María Hernández, PhD, president and COO of Impact 4 Health, followed with a keynote on how health equity initiatives can transform health care coordination, urging health care organizations to integrate cultural competency, SDOH screenings, and patient-centered strategies into their care models to promote quality health care access for marginalized communities.

The ACCC Executive Board and the international delegation visited the Frauenshuh Cancer Center in St Louis Park, Minnesota, to observe an innovative care model designed for patients with limited or no mobility, which enhances patient comfort and improves care coordination.

Throughout the conference, participants engaged with exhibitors and explored poster sessions in the exhibit hall, which featured a wide variety of topics, including the creation of a centralized medication prior authorization team and the use of AI-leveraged approaches to improving cancer care access for minority populations. This interactive space allowed participants to connect with representatives and gain insights on the latest solutions for enhancing patient care.

Session Highlights

ACCC Celebrates 50 Years

Integration of Community Health Workers in Clinical Practice

Come Together: A Global Perspective on Cancer Care Delivery

2024 ACCC Innovator Award Winner: Leveraging AI to Identify and Monitor Pancreatic Abnormalities

Developing a Malignant Hematology APP Fellowship

 

Photo Slideshow

Read the 2024 #ACCCNOC Buzz Blogs

Rapid Access Diagnostic Clinic Expedites Cancer Treatment


July 19, 2022
The James_Reinbolt and Heuser_ACCCBuzz

This blog post is the third of a five-part series highlighting the achievements of the 2022 ACCC Innovator Award winners before their in-depth presentations at the ACCC 39th National Oncology Conference. You can learn more about the innovations being recognized this year and the people who pioneered them by joining ACCC in West Palm Beach, Fla., on October 12-14, 2022.

The COVID-19 pandemic led many cancer programs and practices across the United States to innovate their care delivery to meet patients where they are at, and Arthur G. James Cancer Hospital and Richard J. Solove Research Institute  (OSUCCC – James) in Columbus, Ohio, is no outlier.

In the summer of 2020, staff at The James Cancer Hospital realized that many patients experiencing symptoms for cancer and those who needed further evaluation to reach a diagnosis were now actively avoiding the hospital given the pandemic. The underlying concern: the global pandemic might result in more patients presenting with late-stage disease that could have been diagnosed earlier. To fill this care gap, The James Cancer Hospital opened a new set of front doors to its facility, The James Cancer Diagnostic Center. “We wanted to ensure all patients with a concern for cancer could be quickly evaluated, even if they didn’t have a confirmed diagnosis. We are now able to rapidly evaluate patients in person or virtually, get the needed testing, and then refer patients to the appropriate sub-specialist in a timely manner,” explains Raquel Reinbolt, MD, medical director at The James Cancer Hospital.

Patients no longer have to return to their primary care provider or another healthcare professional to be evaluated and diagnosed—all these services are now available under one roof. “Another advantage of the [cancer diagnostic center] is that patients can self-refer,” Dr. Reinbolt said. “That, again, makes sure that our front doors are wide open for all who need evaluation for a concern for cancer, even those who aren’t well established in the healthcare system.”

Cancer Center Integration

This rapid-access diagnostic center was inspired by another cancer program. After learning about the diagnostic services at Dana Farber Cancer Institute, David E. Cohn, MD, MBA, FACHE, interim chief executive officer at The James Cancer Hospital, told his staff, “I don’t like telling patients no, they can’t come to our center until they have had these tests done. Not everyone has access to these tests or the ability to get to that point.” Instead of turning people away, the goal of The James Cancer Diagnostic Center is to offer in-house care for anyone who walks through the front doors with a particular symptom or an abnormality from a lab or imaging scan that that needs to be further evaluated to rule out a cancer diagnosis. For those in need of cancer screening services that are considered routine care (e.g., mammograms), they are directed to their primary care provider or other healthcare provider who offers these services.

“We are the experts in cancer care,” said Erin Heuser, MBOE, RT(R)(T), LSSBB, CCMP, lead process engineer at The James Cancer Hospital. “We know how and what tests to give individuals.” Because the diagnostic center is located within The James Cancer Hospital and its staff are all dedicated oncology professionals, they can assist patients in completing and understanding why a certain test or evaluation is required to confirm a cancer diagnosis.

In developing this innovation, the team at The James Cancer Diagnostic Center needed to collaborate closely with the health system’s information technology, patient access, finance, physician, advanced practice provider (APP), and nursing teams. APPs and nurses with hematologic and oncologic expertise were specifically identified to provide care in the diagnostic center. Though the start of the COVID-19 pandemic put plans on hold, it only took about three weeks to fully implement The James Diagnostic Center once all stakeholders agreed that patients needed this service right away.

Realizing Success

For Dr. Reinbolt, one of the keys to the diagnostic center’s success was engaging oncology providers at The James Cancer Hospital from the start. “We want to do all the necessary diagnostic evaluation, make that pathologic diagnosis or whatever confirmation test is necessary, and serve it in a nicely wrapped package to our specialist, so they're not having to spend time on the diagnostic process,” she explains. “Instead, our cancer experts are able to focus on developing a treatment plan and getting that patient to treatment as rapidly as possible.” Further, Dr. Reinbolt and her team were clear when defining the diagnostic clinic’s testing strategies and aligning results with the information their oncologists or specialists need to begin effective treatment planning.

For Heuser, engagement from the nursing and provider team is what continues to drive the diagnostic center’s success. “They are touching base with the patient, from the time that referral comes in until they are actively engaged with either their primary care provider or our sub-specialist,” she explains. “Every step along the way, our nursing and provider team is engaged with patients.” This navigation style ensures no patient falls through the cracks and that all patients completely understand the healthcare process upon entering the clinic—regardless or not of a cancer diagnosis.

To learn more about The James Cancer Diagnostic Center, including an in-depth look at its structure and the services provided to patients, register to attend the ACCC 39th National Oncology Conference this fall. “There will be a great discussion on ways to personalize and rapidly provide cancer diagnostics and care delivery. We will also share the way our program has tried to ensure that patients’ fears related to signs or symptoms that could be concerning for cancer are addressed as promptly as possible,” Dr. Reinbolt said. “I think the more we can personalize the care we're delivering and provide good communication between our patients, the diagnostic providers, and our cancer specialists, the better the patient experience and quality of care delivered.”

Cancer Buzz Podcast at the 2024 NOC

 

News & Media

Creating Equitable Cancer Care for Americans of Asian and Pacific Islander Heritage
AJMC, Oct 15, 2024

Making Cancer Care Easier with Community Bispecific Antibody Programs
AJMC, Oct 15, 2024

Combatting Misconceptions of Clinical Trials to Improve Patient Participation
AJMC, Oct 16, 2024

Community Engagement Culturally-Tailored Care as a Gateway to Advancing Health Equity
AJMC, Oct 16, 2024

Improving Early-Stage Lung Cancer Care
AJMC, Oct 30, 2024

Hawaiʻi Cancer Consortium Tackles Disparities in Clinical Trial Access for Pacific Islanders and Asian Americans
AJMC, Oct 30, 2024

Breaking Barriers in Cancer Research: How Advocacy and Compassionate Care Enhance Clinical Trial Access
Pharmacy Times, Oct 12, 2024

Community Cancer Programs Lead the Way in Expanding Bispecific Therapy Access
Pharmacy Times, Oct 10, 2024

Technology Can Support, Enhance the Work of the Health Care Workforce
Pharmacy Times, Oct 12, 2024

A Collaborative Care Model Recognizes That the Oncology Patient’s Journey Does Not End At Remission
Pharmacy Times, Oct 9, 2024

Pennsylvania Hospital Shows That Community Cancer Centers Can Conduct Phase I Clinical Research
Pharmacy Times, Oct 9, 2024

Wellness Initiatives Spotlighted in ACCC's Opening Poster Exhibit
AJMC, Oct 10,2024

Community Cancer Programs Lead the Way in Expanding Bispecific Therapy Access
Pharmacy Times, Oct 10, 2024

Addressing Global Cancer Care Disparities: Strategies for Equitable Access and Collaboration
Pharmacy Times, Oct 11, 2024

Streamlining Biosimilar Access: How EHR Automation Reduces Delays in Cancer Treatment
Pharmacy Times, Oct 11, 2024

Streamlining PA Process, Promoting Biosimilars With Automated Informatics
AJMC, Oct 11, 2024

2024 National Oncology Conference with an unforgettable 50th anniversary opening gala – ACCC
OncoDaily, Oct 11, 2024

ACCC 41st National Oncology Conference: Realizing Innovation
OncoDaily, Oct 13, 2024

Addressing Psychosocial Needs and Navigating Financial Toxicity Shared the Spotlight at ACCC
AJMC, Oct 15, 2024

Financial Advocacy Should Start Before Patients Learn They Have Cancer, Says Dr Nadine Barrett
AJMC, Oct 15, 2024